🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multicenter, prospective, randomized phase II trial aimed a...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2024-03-01
Trial ID
NCT06272214
Treatments Being Tested
This study is a prospective Bayesian adaptive randomized phase II clinical ...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Start Date
2025-01-01
Trial ID
NCT06936046
Treatments Being Tested
This is a prospective, single center, randomized, double-blinded, placebo-c...
Status
Completed
Location
Medical University of Vienna, Department of Clinical Pharmacology
Start Date
2014-10
Trial ID
NCT02284360
Treatments Being Tested
The use of chemoradiotherapy (CRT), in combination with surgery is the stan...
Status
Completed
Location
Velindre Cancer Centre
Start Date
2019-07-29
Trial ID
NCT03916510
Treatments Being Tested
This study is a prospective cohort clinical trial that aims to investigate ...
Status
Recruiting
Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Start Date
2023-01-16
Trial ID
NCT05872724
Patients with intrahepatic cholangiocarcinoma (IHC) have relatively aggress...
Status
Recruiting
Location
Oslo University Hospital
Start Date
2024-02-13
Trial ID
NCT06313203
Treatments Being Tested
Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2005-04-07
Trial ID
NCT00186888
The purpose of this study is to evaluate the safety, performance and usabil...
Status
Completed
Location
Oklahoma University
Start Date
2013-11
Trial ID
NCT01851772
Treatments Being Tested
This Phase III multicenter trial investigates treatment intensification for...
Status
Active Not Recruiting
Location
Chongqing University Cancer Hospital
Start Date
2025-10-04
Trial ID
NCT07248670
Treatments Being Tested
Tislelizumab combined with chemotherapy sequential neoadjuvant therapy for ...
Status
Active Not Recruiting
Location
Sichuan Cancer Hospital and Research Institute
Start Date
2021-07-01
Trial ID
NCT05189730
Treatments Being Tested